Now Is A Suitable Moment For A Long-Term Purchase Of Mirum Pharmaceuticals Inc (NASDAQ: MIRM)
Currently, there are 36.96M common shares owned by the public and among those 34.99M shares have been available to trade. Insiders at the company have transacted a total of 47 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 28 of these insider trades were purchases, […]
